MarketLens
Sign Up

What Caused uniQure's Dramatic Stock Plunge

6 months ago
SHARE THIS ON:

What Caused uniQure's Dramatic Stock Plunge

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 months ago

CAPR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Capricor

Capricor (NASDAQ: CAPR) shares fell 60% to 70% after FDA staff briefing documents raised significant concerns, per SueWallSt investigation notice.
Stock News1 months ago

uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix

uniQure is shifting gene therapy focus beyond Hemgenix toward CNS pipeline expansion, with AMT-130 as the centerpiece, supported by faster regulatory pathways and a streamlined business model.
Stock News1 months ago

Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up

Ionis Pharmaceuticals shares fell 9% intraday to ~$58.30 from a $64.27 open, as negative news continues to accumulate.

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

Elon Musk Is Spending $119 Billion on A Single Building Outside Houston. Here's Who Actually Profits.

Stock News2 hours ago

Dow Falls On News Of U.S.-Iran Attacks; Apple Slides

Stock News2 hours ago

Amazon accused in new suit filed by FTC and 22 states of rigging ad auctions to inflate prices

Stock News3 hours ago

You Could Buy Nvidia for Its 106% Revenue Growth and 75% Gross Margin. But There's an Even Better Reason the AI Stock Has Room to Run.

Stock News3 hours ago

Tesla Stock Has Been on a Hot Streak Ahead of Big Event This Week